It is a agriculture private limited company based in Mumbai, Maharashtra, India, established in 2003.
2003 | Mumbai, Maharashtra, India | ActiveLucid Pharma Private Limited, a active private limited company, was established on 04 November 2003 in Mumbai, Maharashtra, India. Engaging in horticulture & produce within the agriculture, forestry, fishing sector, it holds CIN: U01400MH2003PTC142980. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.55 Cr and a paid-up capital of ₹2.10 Cr.
It upholds a compliant status. Its leadership includes Kewal Chand Dakalia (Director), Ummed Singh (Additional Director), Vikram Singh Rathore (Director). Past directors included Amit Chintaman Patil, Naunand Kanwar, Gajendra Singh Sekhawat. It holds no open charges and ₹9.20 Cr settled loans. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at 111, Mumbai Market Building Near Ac Market, Tardeo, Mumbai, Maharashtra, 400034.
U01400MH2003PTC142980
142980
04 November 2003
₹2.55 Cr
₹2.10 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Lucid Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kewal Chand Dakalia | Director | 06 Mar 2014 | Current |
| Ummed Singh | Additional Director | 25 Apr 2019 | Current |
| Vikram Singh Rathore | Director | 01 Sep 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Nov 2011 | Past |
| Pramod Abcsdd | Director | 01 Nov 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2012 | Past |
| Pramod Abcsdd | Director | 31 Oct 2019 | Past |
| Pramod Abcsdd | Director | 01 Nov 2011 | Past |
| Pramod Abcsdd | Director | 10 Apr 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lucid Pharma Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 1129.48% increase in profit. The company's net worth moved up by a moderate rise of 1.77%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Lucid Pharma had a promoter holding of 36.76% and a public holding of 63.24%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹92,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Dec 2005 | Bank Of Maharashtra | ₹4.60 Cr | Satisfied |
| 21 Dec 2005 | Bank Of Maharashtra | ₹4.60 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Lucid Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lucid Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lucid Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Ummed Singh was appointed as a Additional Director was appointed as a Additional Director on 25 Apr 2019 & has been associated with this company since 6 years 7 months . was completed.
Progress on Lucid Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was documented.
The activity Lucid Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai. was completed.
Progress on Vikram Singh Rathore was appointed as a Director was appointed as a Director on 01 Sep 2014 & has been associated with this company since 11 years 2 months . was documented.
Kewal Chand Dakalia was appointed as a Director was appointed as a Director on 06 Mar 2014 & has been associated with this company since 11 years 8 months . was recorded as a recent event.
Progress on A charge registered on 26 Dec 2005 via Charge ID 80006963 with Bank Of Maharashtra was fully satisfied on 26 Aug 2008. was documented.
The CIN of Lucid Pharma Private Limited is U01400MH2003PTC142980.
Lucid Pharma Private Limited is headquartered at 111, Mumbai Market Building Near Ac Market, Tardeo, Mumbai, Maharashtra, 400034.
Lucid Pharma Private Limited was incorporated on 04 November 2003.
The current directors of Lucid Pharma Private Limited are
The primary industry of Lucid Pharma Private Limited is Agriculture, Forestry, Fishing.
Lucid Pharma Private Limited is unlisted.
The authorized capital of Lucid Pharma Private Limited is ₹2.55 Cr, and the paid-up capital is ₹2.10 Cr.
The compliance status of Lucid Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX